Singapore
National University Health System (NUHS) - National University Cancer Institute
Endometrial cancer, immune checkpoint inhibitors, mismatch repair, prognosis, survival
Ovarian Neoplasms, Platinum-resistant, BRCA wild type, PARP inhibitor, Immunotherapy
ovarian cancer, intraperitoneal chemotherapy, immune response
Endometrial cancer, genomic instability, homologous recombination deficiency, predictive biomarkers, personalized treatment